EUCTR2021-003573-58-BE进行中（未招募）1 期
Vaccination against cOvid-19 In CancEr: booster shot BNT161b2 vaccine after full vaccination with ChAdOx1-S vaccine (Tri-VOICE plus) - Tri-VOICE plus
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 182
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with oncological or hematological malignancy
- •Vaccinated with priming and boosting ChAd-0x1-S vaccine
- •Ability to provide informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 100
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 100
排除标准
- •Women who are pregnant or breastfeeding
- •Immune deficiency not related to cancer or cancer treatment
- •Allergy (multiple)
研究者
相似试验
进行中（未招募）
1 期
Vaccination against cOvid-19 In CancER patients under active treatment in BelgiumOnco-hematological patientsEUCTR2021-000300-38-BEAntwerp University Hospital200
进行中（未招募）
1 期
Vaccination against cOvid In CancErsolid tumorsEUCTR2021-000872-13-NLniversity Medical Center Groningen873
招募中
不适用
Vaccination against cOvid In CancErNL-OMON52037niversitair Medisch Centrum Groningen873
Unknown
不适用
The booster vaccination of the COVID-19 vaccine and its effect for preventing death in COVID-19 infected patients hospitalized in Si Sa Ket HospitalBooster dose of covid-19 vaccine can prevent death in hospitalized with covid-19 casesefficacycovid-19 vaccinebooster immunizationTCTR20230622004/A1,855
已完成
2 期
COVID-19 vaccine boost to enhance immunity (The Booster Study)COVID-19Infection - Studies of infection and infectious agentsRespiratory - Other respiratory disorders / diseasesACTRN12622000411741niversity of Melbourne52